{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:54:57Z","timestamp":1792598097754,"version":"4.5.0"},"reference-count":29,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:00:00Z","timestamp":1712102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: This systematic review aimed to evaluate the impact of antiresorptive drug therapy on osseointegrated dental implants and the association with medication-related osteonecrosis of the jaw (MRONJ). Methods: A systematic search, including a computer search of several databases with specific keywords, a reference search, and a manual search of four key maxillofacial journals were performed. Relevant articles were then evaluated and those that fulfilled the five predetermined criteria were chosen to enter the final review. A total of 445 implants in 135 subjects were included in the eight studies analyzed in the final review. Results: The failure rate of dental implants after antiresorptive medication in the included studies was 23%, with 83% of failures attributed to MRONJ. The average time from antiresorptive drug initiation to MRONJ development was approximately 34 months, ranging from 3 months to 16 years. The majority of MRONJ cases were classified as stage 2, and all sites showed either complete healing or substantial mucosal coverage after treatment. Conclusions: This review highlights the significant impact of antiresorptive drugs on osseo- integrated implants, with MRONJ identified as a leading cause of implant failure. The potential role of peri-implantitis as a trigger for MRONJ is emphasized. Regular monitoring and maintaining good periodontal health, especially within the first three years of antiresorptive drug therapy initiation, are crucial for implant success. Physicians and dentists should provide comprehensive information to patients prescribed with antiresorptive drugs, emphasizing the need for an awareness of the risks of MRONJ in the context of osseointegrated implants. A longer term of follow-up is recommended to identify and manage MRONJ around dental implants in an early manner.<\/jats:p>","DOI":"10.3390\/jcm13072091","type":"journal-article","created":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T08:42:34Z","timestamp":1712133754000},"page":"2091","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Effect of Antiresorptive Drugs on Osseointegrated Dental Implants: A Systematic Review"],"prefix":"10.3390","volume":"13","author":[{"given":"Joyce Tin Wing","family":"Li","sequence":"first","affiliation":[{"name":"Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Pok Fu Lam, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6670-6570","authenticated-orcid":false,"given":"Yiu Yan","family":"Leung","sequence":"additional","affiliation":[{"name":"Oral and Maxillofacial Surgery, Faculty of Dentistry, The University of Hong Kong, Pok Fu Lam, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,4,3]]},"reference":[{"key":"ref_1","unstructured":"Berenson, J.R., and Stopeck, A.T. (2024, February 18). Risks of Therapy with Bone Antiresorptive Agents in Patients with Advanced Malignancy. Available online: https:\/\/www.uptodate.com\/contents\/risks-of-therapy-with-bone-antiresorptive-agents-in-patients-with-advanced-malignancy."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws\u20142022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1007\/s00198-023-06732-8","article-title":"Incidence and trend of antiresorptive agent-related osteonecrosis of the jaw from 2016 to 2020 in Kure, Japan","volume":"34","author":"Kunihara","year":"2023","journal-title":"Osteoporos. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1200\/JCO.2003.99.132","article-title":"Bisphosphanates and oral cavity avascular bone necrosis","volume":"21","author":"Migliorati","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: A review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5397","DOI":"10.1007\/s00520-020-05374-4","article-title":"Current knowledge regarding medication-related osteonecrosis of the jaw among different health professionals","volume":"28","author":"Montezuma","year":"2020","journal-title":"Support Care Cancer"},{"key":"ref_8","first-page":"830","article-title":"Physicians\u2019 awareness of bisphosphonates-related osteonecrosis of the jaw","volume":"32","author":"Mishriky","year":"2011","journal-title":"Saudi Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/0022034514538820","article-title":"Diabetes and Oral Implant Failure:A Systematic Review","volume":"93","author":"Chrcanovic","year":"2014","journal-title":"J. Dent. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.ebd.6401214","article-title":"Implant outcomes poorer in patients with history of periodontal disease","volume":"18","author":"Keenan","year":"2017","journal-title":"Evid.-Based Dent."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jebdp.2016.06.002","article-title":"No Clear Evidence Regarding the Effect of Osteoporosis on Dental Implant Failure","volume":"16","author":"Alqutaibi","year":"2016","journal-title":"J. Evid. Based Dent. Pract."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"n160","DOI":"10.1136\/bmj.n160","article-title":"PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.bjoms.2020.03.022","article-title":"Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ)","volume":"58","author":"Pichardo","year":"2020","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1937.e1","DOI":"10.1016\/j.joms.2014.04.037","article-title":"Effect of Dental Implants on Bisphosphonate-Related Osteonecrosis of the Jaws","volume":"72","author":"Holzinger","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.joms.2009.09.037","article-title":"The Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in Dental Implant Patients: A South Australian Case Series","volume":"68","author":"Goss","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e743","DOI":"10.1016\/j.jormas.2021.12.002","article-title":"Is medication related osteonecrosis of the jaw around implants a rare entity? A case series with a focus on etiopathophysiology","volume":"123","author":"Massaad","year":"2022","journal-title":"J. Stomatol. Oral Maxillofac. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/clr.12088","article-title":"Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment","volume":"25","author":"Kwon","year":"2014","journal-title":"Clin. Oral Implant. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijom.2017.07.012","article-title":"Previously successful dental implants can fail when patients commence anti-resorptive therapy\u2014A case series","volume":"47","author":"Pogrel","year":"2018","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1708-8208.2009.00150.x","article-title":"Implant Placement in Patients with Oral Bisphosphonate Therapy: A Case Series","volume":"12","author":"Shabestari","year":"2010","journal-title":"Clin. Implant Dent. Relat. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1007\/s00198-019-05257-3","article-title":"Effects of anti-resorptive drugs on implant survival and peri-implantitis in patients with existing osseointegrated dental implants: A retrospective cohort study","volume":"31","author":"Kim","year":"2020","journal-title":"Osteoporos. Int."},{"key":"ref_21","unstructured":"(2024, January 24). European Federation of Periodontology Home Page. Available online: https:\/\/www.efp.org\/faqs\/#:~:text=Implants%20are%20also%20not%20suitable,tissue)%20develops%20suddenly%20and%20quickly."},{"key":"ref_22","unstructured":"(2019). Guidance on the Standards of Care for NHS-Funded Dental Implant Treatment 2019, Royal College of Surgeons of England Faculty of Dentistry."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00784-012-0708-2","article-title":"Osteopathology induced by bisphosphonates and dental implants: Clinical observations","volume":"17","author":"Jacobsen","year":"2013","journal-title":"Clin. Oral Investig."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.joms.2009.09.017","article-title":"Bisphosphonate-Related Osteonecrosis of the Jaw Associated With Dental Implants","volume":"68","author":"Lazarovici","year":"2010","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/01.id.0000236120.22719.02","article-title":"Dental Endosseous Implants in Patients on Bisphosphonate Therapy","volume":"15","author":"Scully","year":"2006","journal-title":"Implant Dent."},{"key":"ref_26","first-page":"E755","article-title":"Oral implants in patients receiving bisphosphonates: A review and update","volume":"13","year":"2008","journal-title":"Med. Oral Patol. Oral Cirug\u00eda Bucal"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1563\/aaid-joi-D-19-00385","article-title":"Medication-Related Osteonecrosis of the Jaw Subsequent to Peri-Implantitis: A Case Report and Literature Review","volume":"47","author":"Seki","year":"2021","journal-title":"J. Oral Implantol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/odi.13873","article-title":"Peri-implantitis-like medication-related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope","volume":"28","author":"Tempesta","year":"2022","journal-title":"Oral Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jcms.2016.09.018","article-title":"Clinical features of peri-implant medication-related osteonecrosis of the jaw: Is there an association to peri-implantitis?","volume":"44","author":"Troeltzsch","year":"2016","journal-title":"J. Cranio-Maxillofac. Surg."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/7\/2091\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:23:00Z","timestamp":1760106180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/13\/7\/2091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,3]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["jcm13072091"],"URL":"https:\/\/doi.org\/10.3390\/jcm13072091","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,3]]}}}